8 results
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
called guanylate cyclase stimulators, which include Adempas® (riociguat), a medicine that treats pulmonary arterial hypertension and chronic
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
15 Nov 22
Petros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Update
8:30am
that treats pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
are allergic to avanafil or any of the ingredients
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
15 Aug 22
Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022
9:16am
hypertension and chronic thromboembolic pulmonary hypertension
are allergic to avanafil or any of the ingredients in STENDRA®
Stop sexual activity and get
8-K
EX-99.1
kfhtp1 5bo
4 Apr 22
Petros Pharmaceuticals Reports Year End 2021 Financial Results and Corporate Highlights
4:15pm
8-K
EX-99.1
qvqmmlmbp5fcb5dc7
16 Nov 21
Petros Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
12:00am
8-K
EX-99.1
w0x36
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
- Prev
- 1
- Next